nodes	percent_of_prediction	percent_of_DWPC	metapath
Trimipramine—SLC6A3—Gilles de la Tourette syndrome	0.37	0.431	CbGaD
Trimipramine—DRD2—Gilles de la Tourette syndrome	0.275	0.321	CbGaD
Trimipramine—HTR2A—Gilles de la Tourette syndrome	0.213	0.248	CbGaD
Trimipramine—SLC6A2—autonomic nervous system—Gilles de la Tourette syndrome	0.0053	0.123	CbGeAlD
Trimipramine—HTR2A—autonomic nervous system—Gilles de la Tourette syndrome	0.00318	0.074	CbGeAlD
Trimipramine—ADRA1B—nervous system—Gilles de la Tourette syndrome	0.00111	0.0258	CbGeAlD
Trimipramine—ADRA1B—central nervous system—Gilles de la Tourette syndrome	0.00107	0.0248	CbGeAlD
Trimipramine—SLC6A3—midbrain—Gilles de la Tourette syndrome	0.00101	0.0235	CbGeAlD
Trimipramine—HTR3A—nervous system—Gilles de la Tourette syndrome	0.000998	0.0232	CbGeAlD
Trimipramine—HTR1D—midbrain—Gilles de la Tourette syndrome	0.000987	0.0229	CbGeAlD
Trimipramine—HTR2C—midbrain—Gilles de la Tourette syndrome	0.000977	0.0227	CbGeAlD
Trimipramine—HTR3A—central nervous system—Gilles de la Tourette syndrome	0.000961	0.0223	CbGeAlD
Trimipramine—SLC6A4—midbrain—Gilles de la Tourette syndrome	0.000926	0.0215	CbGeAlD
Trimipramine—ADRA1B—brain—Gilles de la Tourette syndrome	0.000848	0.0197	CbGeAlD
Trimipramine—SLC6A3—nervous system—Gilles de la Tourette syndrome	0.000831	0.0193	CbGeAlD
Trimipramine—HTR1A—midbrain—Gilles de la Tourette syndrome	0.000822	0.0191	CbGeAlD
Trimipramine—HTR1D—nervous system—Gilles de la Tourette syndrome	0.000811	0.0188	CbGeAlD
Trimipramine—HTR2C—nervous system—Gilles de la Tourette syndrome	0.000803	0.0187	CbGeAlD
Trimipramine—SLC6A3—central nervous system—Gilles de la Tourette syndrome	0.0008	0.0186	CbGeAlD
Trimipramine—HTR1D—central nervous system—Gilles de la Tourette syndrome	0.000781	0.0181	CbGeAlD
Trimipramine—HTR2C—central nervous system—Gilles de la Tourette syndrome	0.000773	0.018	CbGeAlD
Trimipramine—HTR3A—brain—Gilles de la Tourette syndrome	0.000763	0.0177	CbGeAlD
Trimipramine—SLC6A4—nervous system—Gilles de la Tourette syndrome	0.000761	0.0177	CbGeAlD
Trimipramine—DRD2—midbrain—Gilles de la Tourette syndrome	0.000743	0.0173	CbGeAlD
Trimipramine—SLC6A4—central nervous system—Gilles de la Tourette syndrome	0.000733	0.017	CbGeAlD
Trimipramine—HTR1A—nervous system—Gilles de la Tourette syndrome	0.000676	0.0157	CbGeAlD
Trimipramine—SLC6A2—nervous system—Gilles de la Tourette syndrome	0.00067	0.0156	CbGeAlD
Trimipramine—HTR1A—central nervous system—Gilles de la Tourette syndrome	0.000651	0.0151	CbGeAlD
Trimipramine—SLC6A2—central nervous system—Gilles de la Tourette syndrome	0.000645	0.015	CbGeAlD
Trimipramine—SLC6A3—brain—Gilles de la Tourette syndrome	0.000635	0.0148	CbGeAlD
Trimipramine—ADRA1A—nervous system—Gilles de la Tourette syndrome	0.000623	0.0145	CbGeAlD
Trimipramine—HTR1D—brain—Gilles de la Tourette syndrome	0.00062	0.0144	CbGeAlD
Trimipramine—HTR2C—brain—Gilles de la Tourette syndrome	0.000614	0.0143	CbGeAlD
Trimipramine—DRD2—nervous system—Gilles de la Tourette syndrome	0.000611	0.0142	CbGeAlD
Trimipramine—ADRA1A—central nervous system—Gilles de la Tourette syndrome	0.0006	0.0139	CbGeAlD
Trimipramine—DRD2—central nervous system—Gilles de la Tourette syndrome	0.000588	0.0137	CbGeAlD
Trimipramine—SLC6A4—brain—Gilles de la Tourette syndrome	0.000582	0.0135	CbGeAlD
Trimipramine—ADRA2A—midbrain—Gilles de la Tourette syndrome	0.000576	0.0134	CbGeAlD
Trimipramine—HTR1A—brain—Gilles de la Tourette syndrome	0.000517	0.012	CbGeAlD
Trimipramine—SLC6A2—brain—Gilles de la Tourette syndrome	0.000512	0.0119	CbGeAlD
Trimipramine—HTR2A—midbrain—Gilles de la Tourette syndrome	0.00049	0.0114	CbGeAlD
Trimipramine—HRH1—nervous system—Gilles de la Tourette syndrome	0.000482	0.0112	CbGeAlD
Trimipramine—ADRA1A—brain—Gilles de la Tourette syndrome	0.000476	0.0111	CbGeAlD
Trimipramine—ADRA2A—nervous system—Gilles de la Tourette syndrome	0.000474	0.011	CbGeAlD
Trimipramine—DRD2—brain—Gilles de la Tourette syndrome	0.000467	0.0109	CbGeAlD
Trimipramine—HRH1—central nervous system—Gilles de la Tourette syndrome	0.000464	0.0108	CbGeAlD
Trimipramine—ADRA2A—central nervous system—Gilles de la Tourette syndrome	0.000456	0.0106	CbGeAlD
Trimipramine—HTR2A—nervous system—Gilles de la Tourette syndrome	0.000403	0.00936	CbGeAlD
Trimipramine—HTR2A—central nervous system—Gilles de la Tourette syndrome	0.000388	0.00901	CbGeAlD
Trimipramine—CYP3A4—nervous system—Gilles de la Tourette syndrome	0.000373	0.00867	CbGeAlD
Trimipramine—HRH1—brain—Gilles de la Tourette syndrome	0.000369	0.00857	CbGeAlD
Trimipramine—CYP2D6—nervous system—Gilles de la Tourette syndrome	0.000367	0.00853	CbGeAlD
Trimipramine—ADRA2A—brain—Gilles de la Tourette syndrome	0.000362	0.00842	CbGeAlD
Trimipramine—CYP3A4—central nervous system—Gilles de la Tourette syndrome	0.000359	0.00835	CbGeAlD
Trimipramine—CYP2D6—central nervous system—Gilles de la Tourette syndrome	0.000353	0.00821	CbGeAlD
Trimipramine—Propiomazine—DRD4—Gilles de la Tourette syndrome	0.000325	0.0442	CrCbGaD
Trimipramine—ABCB1—midbrain—Gilles de la Tourette syndrome	0.000321	0.00746	CbGeAlD
Trimipramine—HTR2A—brain—Gilles de la Tourette syndrome	0.000308	0.00716	CbGeAlD
Trimipramine—Cyamemazine—HTR2A—Gilles de la Tourette syndrome	0.000291	0.0397	CrCbGaD
Trimipramine—Mianserin—DRD3—Gilles de la Tourette syndrome	0.000291	0.0396	CrCbGaD
Trimipramine—CYP2D6—brain—Gilles de la Tourette syndrome	0.000281	0.00652	CbGeAlD
Trimipramine—Benzphetamine—SLC6A3—Gilles de la Tourette syndrome	0.000279	0.038	CrCbGaD
Trimipramine—Methotrimeprazine—DRD4—Gilles de la Tourette syndrome	0.000277	0.0378	CrCbGaD
Trimipramine—Cyclobenzaprine—HTR2A—Gilles de la Tourette syndrome	0.000271	0.0369	CrCbGaD
Trimipramine—Mianserin—SLC6A3—Gilles de la Tourette syndrome	0.000271	0.0369	CrCbGaD
Trimipramine—Epinastine—HTR2A—Gilles de la Tourette syndrome	0.000269	0.0366	CrCbGaD
Trimipramine—ABCB1—nervous system—Gilles de la Tourette syndrome	0.000264	0.00614	CbGeAlD
Trimipramine—ABCB1—central nervous system—Gilles de la Tourette syndrome	0.000254	0.00591	CbGeAlD
Trimipramine—Acepromazine—DRD2—Gilles de la Tourette syndrome	0.000242	0.033	CrCbGaD
Trimipramine—Promazine—DRD4—Gilles de la Tourette syndrome	0.00024	0.0328	CrCbGaD
Trimipramine—Methotrimeprazine—DRD3—Gilles de la Tourette syndrome	0.000239	0.0326	CrCbGaD
Trimipramine—Chlorpromazine—DRD4—Gilles de la Tourette syndrome	0.000212	0.0288	CrCbGaD
Trimipramine—ABCB1—brain—Gilles de la Tourette syndrome	0.000202	0.00469	CbGeAlD
Trimipramine—Mianserin—DRD2—Gilles de la Tourette syndrome	0.000201	0.0274	CrCbGaD
Trimipramine—Desipramine—SLC6A3—Gilles de la Tourette syndrome	0.000199	0.0271	CrCbGaD
Trimipramine—Propiomazine—DRD2—Gilles de la Tourette syndrome	0.000194	0.0264	CrCbGaD
Trimipramine—Acepromazine—HTR2A—Gilles de la Tourette syndrome	0.000187	0.0255	CrCbGaD
Trimipramine—Chlorpromazine—DRD3—Gilles de la Tourette syndrome	0.000182	0.0249	CrCbGaD
Trimipramine—Amitriptyline—DRD3—Gilles de la Tourette syndrome	0.00018	0.0246	CrCbGaD
Trimipramine—Nortriptyline—DRD2—Gilles de la Tourette syndrome	0.00018	0.0245	CrCbGaD
Trimipramine—Imipramine—SLC6A3—Gilles de la Tourette syndrome	0.000169	0.023	CrCbGaD
Trimipramine—Methotrimeprazine—DRD2—Gilles de la Tourette syndrome	0.000166	0.0226	CrCbGaD
Trimipramine—Promethazine—DRD2—Gilles de la Tourette syndrome	0.000163	0.0222	CrCbGaD
Trimipramine—Doxepin—DRD2—Gilles de la Tourette syndrome	0.000161	0.022	CrCbGaD
Trimipramine—Mianserin—HTR2A—Gilles de la Tourette syndrome	0.000156	0.0212	CrCbGaD
Trimipramine—HTR3A—Transmembrane transport of small molecules—SLC6A3—Gilles de la Tourette syndrome	0.000154	0.00167	CbGpPWpGaD
Trimipramine—HTR1A—G alpha (i) signalling events—DRD4—Gilles de la Tourette syndrome	0.00015	0.00164	CbGpPWpGaD
Trimipramine—DRD2—Circadian rythm related genes—DRD4—Gilles de la Tourette syndrome	0.00015	0.00163	CbGpPWpGaD
Trimipramine—Propiomazine—HTR2A—Gilles de la Tourette syndrome	0.00015	0.0204	CrCbGaD
Trimipramine—HTR1D—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.000149	0.00163	CbGpPWpGaD
Trimipramine—ADRA2B—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.000149	0.00162	CbGpPWpGaD
Trimipramine—Desipramine—DRD2—Gilles de la Tourette syndrome	0.000148	0.0202	CrCbGaD
Trimipramine—ADRA2B—G alpha (i) signalling events—DRD2—Gilles de la Tourette syndrome	0.000145	0.00158	CbGpPWpGaD
Trimipramine—ADRA2B—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.000145	0.00158	CbGpPWpGaD
Trimipramine—HTR1A—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.000144	0.00157	CbGpPWpGaD
Trimipramine—Promazine—DRD2—Gilles de la Tourette syndrome	0.000143	0.0195	CrCbGaD
Trimipramine—HTR2C—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.000143	0.00156	CbGpPWpGaD
Trimipramine—Clomipramine—HTR2A—Gilles de la Tourette syndrome	0.000142	0.0194	CrCbGaD
Trimipramine—HTR1A—G alpha (i) signalling events—DRD2—Gilles de la Tourette syndrome	0.00014	0.00153	CbGpPWpGaD
Trimipramine—HTR1A—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.00014	0.00152	CbGpPWpGaD
Trimipramine—Nortriptyline—HTR2A—Gilles de la Tourette syndrome	0.000139	0.0189	CrCbGaD
Trimipramine—HTR2C—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.000139	0.00151	CbGpPWpGaD
Trimipramine—ADRA1B—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.000137	0.00149	CbGpPWpGaD
Trimipramine—HTR1A—SIDS Susceptibility Pathways—HTR2A—Gilles de la Tourette syndrome	0.000136	0.00148	CbGpPWpGaD
Trimipramine—DRD2—G alpha (i) signalling events—DRD3—Gilles de la Tourette syndrome	0.000136	0.00148	CbGpPWpGaD
Trimipramine—ADRA2B—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.000135	0.00147	CbGpPWpGaD
Trimipramine—ADRA1B—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.000133	0.00145	CbGpPWpGaD
Trimipramine—DRD2—G alpha (i) signalling events—DRD4—Gilles de la Tourette syndrome	0.000132	0.00144	CbGpPWpGaD
Trimipramine—HTR1A—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.00013	0.00142	CbGpPWpGaD
Trimipramine—HTR2C—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.000129	0.00141	CbGpPWpGaD
Trimipramine—Methotrimeprazine—HTR2A—Gilles de la Tourette syndrome	0.000128	0.0174	CrCbGaD
Trimipramine—ADRA2B—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.000128	0.00139	CbGpPWpGaD
Trimipramine—Chlorpromazine—DRD2—Gilles de la Tourette syndrome	0.000126	0.0172	CrCbGaD
Trimipramine—DRD2—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.000126	0.00138	CbGpPWpGaD
Trimipramine—Promethazine—HTR2A—Gilles de la Tourette syndrome	0.000126	0.0172	CrCbGaD
Trimipramine—HTR1D—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.000126	0.00137	CbGpPWpGaD
Trimipramine—Imipramine—DRD2—Gilles de la Tourette syndrome	0.000126	0.0171	CrCbGaD
Trimipramine—Amitriptyline—DRD2—Gilles de la Tourette syndrome	0.000125	0.017	CrCbGaD
Trimipramine—Doxepin—HTR2A—Gilles de la Tourette syndrome	0.000125	0.017	CrCbGaD
Trimipramine—HTR2A—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.000124	0.00135	CbGpPWpGaD
Trimipramine—HRH1—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.000124	0.00135	CbGpPWpGaD
Trimipramine—ADRA2B—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.000124	0.00135	CbGpPWpGaD
Trimipramine—ADRA1B—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.000124	0.00135	CbGpPWpGaD
Trimipramine—HTR1A—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.000123	0.00134	CbGpPWpGaD
Trimipramine—DRD2—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.000123	0.00134	CbGpPWpGaD
Trimipramine—HTR2C—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.000123	0.00134	CbGpPWpGaD
Trimipramine—HTR1D—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.000122	0.00133	CbGpPWpGaD
Trimipramine—HTR1D—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.000122	0.00133	CbGpPWpGaD
Trimipramine—ADRA2A—G alpha (i) signalling events—DRD3—Gilles de la Tourette syndrome	0.000122	0.00133	CbGpPWpGaD
Trimipramine—ADRA1A—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.000122	0.00133	CbGpPWpGaD
Trimipramine—HTR2A—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.000121	0.00131	CbGpPWpGaD
Trimipramine—HRH1—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.00012	0.00131	CbGpPWpGaD
Trimipramine—HTR1A—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.00012	0.0013	CbGpPWpGaD
Trimipramine—HTR2C—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.000119	0.0013	CbGpPWpGaD
Trimipramine—ADRA2A—G alpha (i) signalling events—DRD4—Gilles de la Tourette syndrome	0.000118	0.00129	CbGpPWpGaD
Trimipramine—ADRA1A—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.000118	0.00129	CbGpPWpGaD
Trimipramine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.000117	0.00128	CbGpPWpGaD
Trimipramine—HTR2C—G alpha (q) signalling events—HTR2A—Gilles de la Tourette syndrome	0.000117	0.00128	CbGpPWpGaD
Trimipramine—ADRA2B—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.000115	0.00126	CbGpPWpGaD
Trimipramine—Desipramine—HTR2A—Gilles de la Tourette syndrome	0.000114	0.0156	CrCbGaD
Trimipramine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.000114	0.00124	CbGpPWpGaD
Trimipramine—HTR1D—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.000114	0.00124	CbGpPWpGaD
Trimipramine—ADRA2A—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.000113	0.00123	CbGpPWpGaD
Trimipramine—HTR2A—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.000112	0.00122	CbGpPWpGaD
Trimipramine—ADRA1B—G alpha (q) signalling events—HTR2A—Gilles de la Tourette syndrome	0.000112	0.00122	CbGpPWpGaD
Trimipramine—HRH1—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.000112	0.00122	CbGpPWpGaD
Trimipramine—HTR1A—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.000111	0.00121	CbGpPWpGaD
Trimipramine—Promazine—HTR2A—Gilles de la Tourette syndrome	0.000111	0.0151	CrCbGaD
Trimipramine—HTR2C—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.000111	0.00121	CbGpPWpGaD
Trimipramine—ADRA2A—G alpha (i) signalling events—DRD2—Gilles de la Tourette syndrome	0.00011	0.0012	CbGpPWpGaD
Trimipramine—ADRA1A—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.00011	0.0012	CbGpPWpGaD
Trimipramine—ADRA2A—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.00011	0.0012	CbGpPWpGaD
Trimipramine—DRD2—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.000108	0.00118	CbGpPWpGaD
Trimipramine—HTR2A—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.000106	0.00116	CbGpPWpGaD
Trimipramine—HRH1—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.000106	0.00116	CbGpPWpGaD
Trimipramine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.000106	0.00116	CbGpPWpGaD
Trimipramine—DRD2—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.000105	0.00114	CbGpPWpGaD
Trimipramine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—Gilles de la Tourette syndrome	0.000105	0.00114	CbGpPWpGaD
Trimipramine—HTR1D—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.000105	0.00114	CbGpPWpGaD
Trimipramine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.000104	0.00114	CbGpPWpGaD
Trimipramine—HTR2A—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.000103	0.00113	CbGpPWpGaD
Trimipramine—HRH1—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.000103	0.00112	CbGpPWpGaD
Trimipramine—ADRA2A—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.000102	0.00111	CbGpPWpGaD
Trimipramine—HRH1—G alpha (q) signalling events—HTR2A—Gilles de la Tourette syndrome	0.000102	0.00111	CbGpPWpGaD
Trimipramine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.000101	0.0011	CbGpPWpGaD
Trimipramine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—Gilles de la Tourette syndrome	0.0001	0.00109	CbGpPWpGaD
Trimipramine—ADRA1A—G alpha (q) signalling events—HTR2A—Gilles de la Tourette syndrome	9.97e-05	0.00109	CbGpPWpGaD
Trimipramine—Chlorpromazine—HTR2A—Gilles de la Tourette syndrome	9.76e-05	0.0133	CrCbGaD
Trimipramine—ADRA2B—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	9.72e-05	0.00106	CbGpPWpGaD
Trimipramine—Imipramine—HTR2A—Gilles de la Tourette syndrome	9.71e-05	0.0132	CrCbGaD
Trimipramine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	9.68e-05	0.00105	CbGpPWpGaD
Trimipramine—Amitriptyline—HTR2A—Gilles de la Tourette syndrome	9.65e-05	0.0131	CrCbGaD
Trimipramine—HTR2A—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	9.63e-05	0.00105	CbGpPWpGaD
Trimipramine—HRH1—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	9.61e-05	0.00105	CbGpPWpGaD
Trimipramine—ADRA2B—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	9.44e-05	0.00103	CbGpPWpGaD
Trimipramine—ADRA2B—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	9.44e-05	0.00103	CbGpPWpGaD
Trimipramine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	9.43e-05	0.00103	CbGpPWpGaD
Trimipramine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	9.4e-05	0.00102	CbGpPWpGaD
Trimipramine—HTR1A—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	9.38e-05	0.00102	CbGpPWpGaD
Trimipramine—HTR2C—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	9.33e-05	0.00102	CbGpPWpGaD
Trimipramine—HTR1A—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	9.11e-05	0.000992	CbGpPWpGaD
Trimipramine—HTR1A—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	9.11e-05	0.000992	CbGpPWpGaD
Trimipramine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—Gilles de la Tourette syndrome	9.09e-05	0.00099	CbGpPWpGaD
Trimipramine—HTR2C—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	9.06e-05	0.000987	CbGpPWpGaD
Trimipramine—HTR2C—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	9.06e-05	0.000987	CbGpPWpGaD
Trimipramine—ADRA1B—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	8.94e-05	0.000973	CbGpPWpGaD
Trimipramine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—Gilles de la Tourette syndrome	8.92e-05	0.000971	CbGpPWpGaD
Trimipramine—ADRA2B—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	8.79e-05	0.000957	CbGpPWpGaD
Trimipramine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	8.76e-05	0.000954	CbGpPWpGaD
Trimipramine—ADRA1B—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	8.68e-05	0.000945	CbGpPWpGaD
Trimipramine—ADRA1B—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	8.67e-05	0.000945	CbGpPWpGaD
Trimipramine—HTR1A—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	8.49e-05	0.000924	CbGpPWpGaD
Trimipramine—HTR2C—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	8.44e-05	0.000919	CbGpPWpGaD
Trimipramine—SLC6A2—Transmembrane transport of small molecules—SLC6A3—Gilles de la Tourette syndrome	8.25e-05	0.000899	CbGpPWpGaD
Trimipramine—DRD2—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	8.24e-05	0.000897	CbGpPWpGaD
Trimipramine—HTR2A—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	8.11e-05	0.000883	CbGpPWpGaD
Trimipramine—HRH1—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	8.09e-05	0.000881	CbGpPWpGaD
Trimipramine—ADRA2B—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	8.08e-05	0.000881	CbGpPWpGaD
Trimipramine—ADRA1B—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	8.08e-05	0.00088	CbGpPWpGaD
Trimipramine—DRD2—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	8e-05	0.000871	CbGpPWpGaD
Trimipramine—DRD2—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	8e-05	0.000871	CbGpPWpGaD
Trimipramine—HTR1D—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	7.97e-05	0.000868	CbGpPWpGaD
Trimipramine—ADRA1A—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	7.94e-05	0.000864	CbGpPWpGaD
Trimipramine—HTR2A—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	7.87e-05	0.000857	CbGpPWpGaD
Trimipramine—HRH1—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	7.85e-05	0.000855	CbGpPWpGaD
Trimipramine—HRH1—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	7.85e-05	0.000855	CbGpPWpGaD
Trimipramine—HTR1A—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	7.8e-05	0.00085	CbGpPWpGaD
Trimipramine—HTR2C—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	7.76e-05	0.000846	CbGpPWpGaD
Trimipramine—ADRA1A—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	7.71e-05	0.000839	CbGpPWpGaD
Trimipramine—ADRA1A—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	7.71e-05	0.000839	CbGpPWpGaD
Trimipramine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	7.43e-05	0.00081	CbGpPWpGaD
Trimipramine—ADRA2A—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	7.37e-05	0.000803	CbGpPWpGaD
Trimipramine—HTR2A—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	7.33e-05	0.000798	CbGpPWpGaD
Trimipramine—HRH1—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	7.31e-05	0.000797	CbGpPWpGaD
Trimipramine—ADRA1A—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	7.18e-05	0.000782	CbGpPWpGaD
Trimipramine—ADRA2A—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	7.16e-05	0.00078	CbGpPWpGaD
Trimipramine—ADRA2A—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	7.16e-05	0.00078	CbGpPWpGaD
Trimipramine—HTR1D—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	7.11e-05	0.000774	CbGpPWpGaD
Trimipramine—ADRA2A—Metabolism—HDC—Gilles de la Tourette syndrome	7.07e-05	0.00077	CbGpPWpGaD
Trimipramine—HTR1D—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	6.9e-05	0.000752	CbGpPWpGaD
Trimipramine—DRD2—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	6.85e-05	0.000746	CbGpPWpGaD
Trimipramine—HRH1—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	6.73e-05	0.000733	CbGpPWpGaD
Trimipramine—ADRA2A—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	6.67e-05	0.000726	CbGpPWpGaD
Trimipramine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	6.6e-05	0.000719	CbGpPWpGaD
Trimipramine—HTR1D—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	6.46e-05	0.000703	CbGpPWpGaD
Trimipramine—HTR1D—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	6.43e-05	0.0007	CbGpPWpGaD
Trimipramine—HTR1D—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	6.27e-05	0.000683	CbGpPWpGaD
Trimipramine—ADRA2B—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	6.16e-05	0.000671	CbGpPWpGaD
Trimipramine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	6.13e-05	0.000668	CbGpPWpGaD
Trimipramine—HTR1A—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	5.94e-05	0.000647	CbGpPWpGaD
Trimipramine—HTR2C—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	5.91e-05	0.000644	CbGpPWpGaD
Trimipramine—HTR1D—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	5.84e-05	0.000636	CbGpPWpGaD
Trimipramine—ADRA1B—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	5.66e-05	0.000616	CbGpPWpGaD
Trimipramine—ADRA2B—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	5.49e-05	0.000598	CbGpPWpGaD
Trimipramine—ADRA2B—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	5.33e-05	0.000581	CbGpPWpGaD
Trimipramine—HTR1A—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	5.3e-05	0.000578	CbGpPWpGaD
Trimipramine—HTR2C—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	5.28e-05	0.000575	CbGpPWpGaD
Trimipramine—DRD2—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	5.22e-05	0.000568	CbGpPWpGaD
Trimipramine—HTR1A—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	5.15e-05	0.000561	CbGpPWpGaD
Trimipramine—HRH1—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	5.12e-05	0.000558	CbGpPWpGaD
Trimipramine—HTR2C—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	5.12e-05	0.000558	CbGpPWpGaD
Trimipramine—ADRA1B—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	5.05e-05	0.00055	CbGpPWpGaD
Trimipramine—ADRA1A—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	5.03e-05	0.000548	CbGpPWpGaD
Trimipramine—CYP2C19—Metabolism—HDC—Gilles de la Tourette syndrome	5.01e-05	0.000546	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	4.99e-05	0.000543	CbGpPWpGaD
Trimipramine—ADRA2B—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	4.97e-05	0.000541	CbGpPWpGaD
Trimipramine—ADRA1B—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	4.9e-05	0.000534	CbGpPWpGaD
Trimipramine—ABCB1—Metabolism—HDC—Gilles de la Tourette syndrome	4.89e-05	0.000533	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	4.84e-05	0.000527	CbGpPWpGaD
Trimipramine—HTR1A—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	4.82e-05	0.000524	CbGpPWpGaD
Trimipramine—HTR1A—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	4.8e-05	0.000522	CbGpPWpGaD
Trimipramine—HTR2C—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	4.79e-05	0.000522	CbGpPWpGaD
Trimipramine—HTR2C—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	4.77e-05	0.00052	CbGpPWpGaD
Trimipramine—HTR1A—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	4.67e-05	0.000509	CbGpPWpGaD
Trimipramine—ADRA2A—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	4.67e-05	0.000509	CbGpPWpGaD
Trimipramine—DRD2—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	4.66e-05	0.000507	CbGpPWpGaD
Trimipramine—HTR2C—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	4.65e-05	0.000507	CbGpPWpGaD
Trimipramine—CYP2D6—Metabolism—HDC—Gilles de la Tourette syndrome	4.61e-05	0.000502	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	4.59e-05	0.000499	CbGpPWpGaD
Trimipramine—HTR2A—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	4.58e-05	0.000499	CbGpPWpGaD
Trimipramine—HRH1—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	4.57e-05	0.000498	CbGpPWpGaD
Trimipramine—CYP2C9—Metabolism—HDC—Gilles de la Tourette syndrome	4.57e-05	0.000498	CbGpPWpGaD
Trimipramine—ADRA1B—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	4.57e-05	0.000497	CbGpPWpGaD
Trimipramine—DRD2—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	4.52e-05	0.000492	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	4.51e-05	0.000491	CbGpPWpGaD
Trimipramine—HTR1D—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	4.5e-05	0.00049	CbGpPWpGaD
Trimipramine—ADRA1A—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	4.49e-05	0.000489	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	4.45e-05	0.000485	CbGpPWpGaD
Trimipramine—HTR2A—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	4.45e-05	0.000484	CbGpPWpGaD
Trimipramine—HRH1—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	4.44e-05	0.000483	CbGpPWpGaD
Trimipramine—HTR1A—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	4.35e-05	0.000474	CbGpPWpGaD
Trimipramine—ADRA1A—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	4.35e-05	0.000474	CbGpPWpGaD
Trimipramine—HTR2C—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	4.33e-05	0.000472	CbGpPWpGaD
Trimipramine—DRD2—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	4.23e-05	0.00046	CbGpPWpGaD
Trimipramine—ADRA2A—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	4.17e-05	0.000454	CbGpPWpGaD
Trimipramine—HTR2A—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	4.16e-05	0.000453	CbGpPWpGaD
Trimipramine—HRH1—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	4.15e-05	0.000452	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	4.15e-05	0.000452	CbGpPWpGaD
Trimipramine—HTR2A—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	4.14e-05	0.000451	CbGpPWpGaD
Trimipramine—HRH1—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	4.13e-05	0.00045	CbGpPWpGaD
Trimipramine—DRD2—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	4.1e-05	0.000447	CbGpPWpGaD
Trimipramine—HTR1D—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	4.09e-05	0.000445	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	4.07e-05	0.000444	CbGpPWpGaD
Trimipramine—ADRA1A—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	4.06e-05	0.000442	CbGpPWpGaD
Trimipramine—ADRA2A—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	4.05e-05	0.000441	CbGpPWpGaD
Trimipramine—HTR2A—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	4.04e-05	0.00044	CbGpPWpGaD
Trimipramine—HRH1—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	4.03e-05	0.000439	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	3.95e-05	0.000431	CbGpPWpGaD
Trimipramine—HTR1D—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	3.81e-05	0.000415	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	3.78e-05	0.000412	CbGpPWpGaD
Trimipramine—ADRA2A—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	3.77e-05	0.000411	CbGpPWpGaD
Trimipramine—HTR2A—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	3.76e-05	0.00041	CbGpPWpGaD
Trimipramine—HRH1—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	3.75e-05	0.000409	CbGpPWpGaD
Trimipramine—HTR1D—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	3.7e-05	0.000403	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	3.68e-05	0.000401	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	3.67e-05	0.0004	CbGpPWpGaD
Trimipramine—ABCB1—Transmembrane transport of small molecules—SLC6A3—Gilles de la Tourette syndrome	3.63e-05	0.000396	CbGpPWpGaD
Trimipramine—ADRA2B—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	3.48e-05	0.000379	CbGpPWpGaD
Trimipramine—HTR1D—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	3.45e-05	0.000376	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	3.42e-05	0.000373	CbGpPWpGaD
Trimipramine—HTR1A—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	3.36e-05	0.000366	CbGpPWpGaD
Trimipramine—HTR2C—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	3.34e-05	0.000364	CbGpPWpGaD
Trimipramine—ADRA1B—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	3.2e-05	0.000348	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	3.16e-05	0.000344	CbGpPWpGaD
Trimipramine—HTR1A—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	3.05e-05	0.000332	CbGpPWpGaD
Trimipramine—HTR2C—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	3.03e-05	0.00033	CbGpPWpGaD
Trimipramine—CYP3A4—Metabolism—HDC—Gilles de la Tourette syndrome	3.01e-05	0.000328	CbGpPWpGaD
Trimipramine—DRD2—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	2.95e-05	0.000321	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	2.95e-05	0.000321	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	2.9e-05	0.000316	CbGpPWpGaD
Trimipramine—HRH1—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	2.9e-05	0.000315	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	2.86e-05	0.000312	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	2.84e-05	0.00031	CbGpPWpGaD
Trimipramine—ADRA1A—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	2.84e-05	0.000309	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	2.83e-05	0.000308	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	2.76e-05	0.000301	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	2.75e-05	0.000299	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	2.71e-05	0.000295	CbGpPWpGaD
Trimipramine—DRD2—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	2.68e-05	0.000292	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	2.66e-05	0.00029	CbGpPWpGaD
Trimipramine—ADRA2A—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	2.64e-05	0.000288	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	2.63e-05	0.000286	CbGpPWpGaD
Trimipramine—HRH1—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	2.63e-05	0.000286	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	2.58e-05	0.000281	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	2.57e-05	0.00028	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	2.56e-05	0.000279	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	2.5e-05	0.000272	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	2.46e-05	0.000268	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	2.45e-05	0.000267	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	2.45e-05	0.000267	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	2.42e-05	0.000264	CbGpPWpGaD
Trimipramine—HTR1D—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	2.42e-05	0.000263	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	2.41e-05	0.000262	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	2.4e-05	0.000261	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	2.39e-05	0.00026	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	2.38e-05	0.000259	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	2.34e-05	0.000254	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	2.24e-05	0.000244	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	2.22e-05	0.000242	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	2.22e-05	0.000242	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	2.18e-05	0.000237	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	2.17e-05	0.000236	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	2.02e-05	0.00022	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.87e-05	0.000203	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.8e-05	0.000196	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.79e-05	0.000195	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.72e-05	0.000187	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.58e-05	0.000172	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.55e-05	0.000169	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.52e-05	0.000166	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.42e-05	0.000154	CbGpPWpGaD
